AU2016305103C1 - Single-molecule sequencing of plasma DNA - Google Patents

Single-molecule sequencing of plasma DNA Download PDF

Info

Publication number
AU2016305103C1
AU2016305103C1 AU2016305103A AU2016305103A AU2016305103C1 AU 2016305103 C1 AU2016305103 C1 AU 2016305103C1 AU 2016305103 A AU2016305103 A AU 2016305103A AU 2016305103 A AU2016305103 A AU 2016305103A AU 2016305103 C1 AU2016305103 C1 AU 2016305103C1
Authority
AU
Australia
Prior art keywords
dna fragments
concatemer
dna
sequence
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016305103A
Other languages
English (en)
Other versions
AU2016305103A1 (en
AU2016305103B2 (en
Inventor
Suk Hang Cheng
Rossa Wai Kwun Chiu
Yuk-Ming Dennis Lo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese University of Hong Kong CUHK
Original Assignee
Chinese University of Hong Kong CUHK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese University of Hong Kong CUHK filed Critical Chinese University of Hong Kong CUHK
Publication of AU2016305103A1 publication Critical patent/AU2016305103A1/en
Application granted granted Critical
Publication of AU2016305103B2 publication Critical patent/AU2016305103B2/en
Priority to AU2020202153A priority Critical patent/AU2020202153B2/en
Publication of AU2016305103C1 publication Critical patent/AU2016305103C1/en
Priority to AU2023202572A priority patent/AU2023202572B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/50—Other enzymatic activities
    • C12Q2521/501—Ligase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/151—Modifications characterised by repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/191—Modifications characterised by incorporating an adaptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/197—Modifications characterised by incorporating a spacer/coupling moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/146—Concentration of target or template
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/631—Detection means characterised by use of a special device being a biochannel or pore

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
AU2016305103A 2015-08-12 2016-08-12 Single-molecule sequencing of plasma DNA Active AU2016305103C1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2020202153A AU2020202153B2 (en) 2015-08-12 2020-03-26 Single-molecule sequencing of plasma DNA
AU2023202572A AU2023202572B2 (en) 2015-08-12 2023-04-27 Single-molecule sequencing of plasma DNA

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562204396P 2015-08-12 2015-08-12
US62/204,396 2015-08-12
PCT/CN2016/094802 WO2017025059A1 (en) 2015-08-12 2016-08-12 Single-molecule sequencing of plasma dna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2020202153A Division AU2020202153B2 (en) 2015-08-12 2020-03-26 Single-molecule sequencing of plasma DNA

Publications (3)

Publication Number Publication Date
AU2016305103A1 AU2016305103A1 (en) 2018-03-22
AU2016305103B2 AU2016305103B2 (en) 2020-01-02
AU2016305103C1 true AU2016305103C1 (en) 2020-06-04

Family

ID=57983895

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2016305103A Active AU2016305103C1 (en) 2015-08-12 2016-08-12 Single-molecule sequencing of plasma DNA
AU2020202153A Active AU2020202153B2 (en) 2015-08-12 2020-03-26 Single-molecule sequencing of plasma DNA
AU2023202572A Active AU2023202572B2 (en) 2015-08-12 2023-04-27 Single-molecule sequencing of plasma DNA

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2020202153A Active AU2020202153B2 (en) 2015-08-12 2020-03-26 Single-molecule sequencing of plasma DNA
AU2023202572A Active AU2023202572B2 (en) 2015-08-12 2023-04-27 Single-molecule sequencing of plasma DNA

Country Status (12)

Country Link
US (2) US11319586B2 (cg-RX-API-DMAC7.html)
EP (1) EP3334843A4 (cg-RX-API-DMAC7.html)
JP (3) JP6867045B2 (cg-RX-API-DMAC7.html)
CN (2) CN115433769A (cg-RX-API-DMAC7.html)
AU (3) AU2016305103C1 (cg-RX-API-DMAC7.html)
CA (1) CA2995422A1 (cg-RX-API-DMAC7.html)
HK (1) HK1248286A1 (cg-RX-API-DMAC7.html)
IL (3) IL285795B (cg-RX-API-DMAC7.html)
MY (1) MY188348A (cg-RX-API-DMAC7.html)
SA (1) SA518390907B1 (cg-RX-API-DMAC7.html)
TW (2) TWI793586B (cg-RX-API-DMAC7.html)
WO (1) WO2017025059A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111356772B (zh) 2017-08-23 2023-10-03 豪夫迈·罗氏有限公司 酶筛选方法
WO2019051244A1 (en) * 2017-09-07 2019-03-14 Coopersurgical, Inc. SYSTEMS AND METHODS FOR NON-EFFRACTIVE PREIMPLANTATORY GENETIC DIAGNOSIS
WO2019084158A1 (en) 2017-10-26 2019-05-02 Ultima Genomics, Inc. METHODS AND SYSTEMS FOR SEQUENCE CALL
EP3731959B1 (en) 2017-12-29 2025-10-08 Clear Labs, Inc. Automated priming and library loading device
US12378603B2 (en) 2018-04-20 2025-08-05 The Regents Of The University Of California Nucleic acid sequencing methods and computer-readable media for practicing same
EP3939047B1 (en) 2019-03-10 2025-09-17 Ultima Genomics, Inc. Methods and systems for sequence calling
EP3987525A1 (en) 2019-06-21 2022-04-27 CooperSurgical, Inc. System and method for determining genetic relationships between a sperm provider, oocyte provider, and the respective conceptus
US20220411863A1 (en) * 2019-11-25 2022-12-29 William Marsh Rice University Linear dna assembly for nanopore sequencing
WO2022008641A1 (en) 2020-07-08 2022-01-13 Roche Sequencing Solutions, Inc. Split-pool synthesis apparatus and methods of performing split-pool synthesis
JP2023545478A (ja) 2020-10-15 2023-10-30 カパ バイオシステムズ，インコーポレイティド 次世代配列決定ライブラリ調製のための電気泳動デバイスおよび方法
CN114507708A (zh) * 2020-11-16 2022-05-17 唐纳德·李 一种制备长分子测序dna的方法
EP4308723B1 (en) 2021-03-15 2025-04-23 F. Hoffmann-La Roche AG Targeted next-generation sequencing via anchored primer extension
JP7657961B2 (ja) 2021-03-26 2025-04-07 エフ． ホフマン－ラ ロシュ アーゲー ハイブリダイゼーション緩衝調合物
EP4314337A1 (en) 2021-04-01 2024-02-07 F. Hoffmann-La Roche AG Immune cell counting of sars-cov-2 patients based on immune repertoire sequencing
CN117545855A (zh) * 2021-04-12 2024-02-09 香港中文大学 使用电信号的碱基修饰分析
WO2023023561A1 (en) * 2021-08-17 2023-02-23 Quantapore, Inc. Multiplex binding assays with optical nanopore readout
US20250243536A1 (en) * 2021-10-18 2025-07-31 Belgian Volition Srl Use of nanopore sequencing for determining the origin of circulating dna
US20250368983A1 (en) 2022-06-30 2025-12-04 Kapa Biosystems, Inc. Controlling for tagmentation sequencing library insert size using archaeal histone-like proteins
CN114898802B (zh) * 2022-07-14 2022-09-30 臻和(北京)生物科技有限公司 基于血浆游离dna甲基化测序数据的末端序列频率分布特征确定方法、评价方法及装置
CN119895049A (zh) 2022-09-02 2025-04-25 豪夫迈·罗氏有限公司 对下一代靶标富集性能的改进
WO2024215528A1 (en) 2023-04-13 2024-10-17 Ventana Medical Systems, Inc. Proliferation assay for fixed solid tumors
WO2024256358A2 (en) 2023-06-14 2024-12-19 F. Hoffmann-La Roche Ag Accelerated marking of 5-formyl cytosine and use in nucleic acid methylation sequencing
WO2025193604A1 (en) 2024-03-11 2025-09-18 Ventana Medical Systems, Inc. Non-enzymatic dissociation of ffpe tissue and generation of single cells with intact cell surface markers
WO2025210056A1 (en) 2024-04-03 2025-10-09 Roche Sequencing Solutions, Inc. In vitro amplification of dna methylation patterns
WO2025247632A1 (en) 2024-05-27 2025-12-04 European Molecular Biology Laboratory Preparation of cell-free fragmented nucleic acids for genetic analysis sequencing

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1225234A2 (en) * 2001-01-20 2002-07-24 Agilent Technologies, Inc. (a Delaware corporation) Synthesis of nucleic acid
WO2006095169A1 (en) * 2005-03-08 2006-09-14 Lingvitae As Method for preparing polynucleotides for analysis
US20120045771A1 (en) * 2008-12-11 2012-02-23 Febit Holding Gmbh Method for analysis of nucleic acid populations
US20130040827A1 (en) * 2011-08-14 2013-02-14 Stephen C. Macevicz Method and compositions for detecting and sequencing nucleic acids
WO2016077313A1 (en) * 2014-11-11 2016-05-19 Bgi Shenzhen Multi-pass sequencing

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008161056A (ja) * 2005-04-08 2008-07-17 Hiroaki Mita Ｄｎａ配列解析装置、ｄｎａ配列解析方法およびプログラム
KR102561664B1 (ko) 2007-07-23 2023-07-28 더 차이니즈 유니버시티 오브 홍콩 대규모 병렬 게놈 서열분석을 이용한 태아 염색체 이수성의 진단 방법
US9175341B2 (en) 2008-12-11 2015-11-03 Pacific Biosciences Of California, Inc. Methods for identifying nucleic acid modifications
LT3783110T (lt) 2009-11-05 2023-01-25 The Chinese University Of Hong Kong Vaisiaus genomo analizė iš motinos biologinio mėginio
US8620593B2 (en) 2009-11-06 2013-12-31 The Chinese University Of Hong Kong Size-based genomic analysis
US9121823B2 (en) * 2010-02-19 2015-09-01 The Trustees Of The University Of Pennsylvania High-resolution analysis devices and related methods
KR20120045922A (ko) * 2010-11-01 2012-05-09 엘지전자 주식회사 나노 포어를 포함하는 염기 서열 결정 장치
EP2646579B1 (en) 2010-11-30 2017-06-14 The Chinese University Of Hong Kong Detection of genetic or molecular aberrations associated with cancer
CA2843136C (en) * 2011-07-25 2020-12-29 Oxford Nanopore Technologies Limited Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
KR101974492B1 (ko) * 2011-07-26 2019-05-02 베리나타 헬스, 인코포레이티드 샘플 중 상이한 이수성의 존재 또는 부재를 결정하는 방법
CA2861457A1 (en) 2012-01-20 2013-07-25 Genia Technologies, Inc. Nanopore based molecular detection and sequencing
US9116118B2 (en) 2012-06-08 2015-08-25 Pacific Biosciences Of California, Inc. Modified base detection with nanopore sequencing
WO2013188841A1 (en) * 2012-06-15 2013-12-19 Genia Technologies, Inc. Chip set-up and high-accuracy nucleic acid sequencing
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
GB201215449D0 (en) * 2012-08-30 2012-10-17 Zoragen Biotechnologies Llp Method of detecting chromosonal abnormalities
EP2898100B9 (en) 2012-09-20 2023-08-02 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
EP3495506B1 (en) * 2013-12-11 2023-07-12 AccuraGen Holdings Limited Methods for detecting rare sequence variants
WO2017195391A1 (ja) 2016-05-10 2017-11-16 日本電気株式会社 需給調整システム、制御装置、制御方法、およびプログラム

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1225234A2 (en) * 2001-01-20 2002-07-24 Agilent Technologies, Inc. (a Delaware corporation) Synthesis of nucleic acid
WO2006095169A1 (en) * 2005-03-08 2006-09-14 Lingvitae As Method for preparing polynucleotides for analysis
US20120045771A1 (en) * 2008-12-11 2012-02-23 Febit Holding Gmbh Method for analysis of nucleic acid populations
US20130040827A1 (en) * 2011-08-14 2013-02-14 Stephen C. Macevicz Method and compositions for detecting and sequencing nucleic acids
WO2016077313A1 (en) * 2014-11-11 2016-05-19 Bgi Shenzhen Multi-pass sequencing

Also Published As

Publication number Publication date
JP2018531583A (ja) 2018-11-01
TWI793586B (zh) 2023-02-21
AU2016305103A1 (en) 2018-03-22
CN107849607B (zh) 2022-10-11
EP3334843A4 (en) 2019-01-02
AU2020202153B2 (en) 2023-02-02
CN107849607A (zh) 2018-03-27
HK1248286A1 (zh) 2018-10-12
TWI728994B (zh) 2021-06-01
TW201718874A (zh) 2017-06-01
IL294192A (en) 2022-08-01
MY188348A (en) 2021-12-02
JP6867045B2 (ja) 2021-04-28
AU2016305103B2 (en) 2020-01-02
JP2021118691A (ja) 2021-08-12
TW202130815A (zh) 2021-08-16
US11319586B2 (en) 2022-05-03
US20170044606A1 (en) 2017-02-16
IL257074B (en) 2021-09-30
AU2023202572A1 (en) 2023-05-18
HK1245850A1 (zh) 2018-08-31
WO2017025059A1 (en) 2017-02-16
AU2023202572B2 (en) 2025-04-10
CA2995422A1 (en) 2017-02-16
US20220205038A1 (en) 2022-06-30
IL285795A (en) 2021-09-30
AU2020202153A1 (en) 2020-04-16
IL257074A (en) 2018-03-29
IL285795B (en) 2022-07-01
JP2024113130A (ja) 2024-08-21
SA518390907B1 (ar) 2021-09-08
IL294192B1 (en) 2023-04-01
IL294192B2 (en) 2023-08-01
CN115433769A (zh) 2022-12-06
EP3334843A1 (en) 2018-06-20
JP7506408B2 (ja) 2024-06-26

Similar Documents

Publication Publication Date Title
AU2023202572B2 (en) Single-molecule sequencing of plasma DNA
JP6817259B2 (ja) 癌の検出のための血漿ｄｎａ中のサイズ及び数異常の使用
TWI727938B (zh) 血漿粒線體ｄｎａ分析之應用
JP6073461B2 (ja) 標的大規模並列配列決定法を使用した対立遺伝子比分析による胎児トリソミーの非侵襲的出生前診断
CN110800063A (zh) 使用无细胞dna片段大小检测肿瘤相关变体
TW202146657A (zh) 偵測突變以用於癌症篩選及胎兒分析
CN108026572A (zh) 游离dna的片段化模式的分析
CN113151474A (zh) 用于癌症检测的血浆dna突变分析
CN110023509A (zh) 基因型分型测定中的非独特条形码
HK40083172A (en) Single-molecule sequencing of plasma dna
HK1245850B (en) Single-molecule sequencing of plasma dna
HK40056499A (en) Mutational analysis of plasma dna for cancer detection
HK1240279B (zh) 使用血浆dna的尺寸和数目畸变检测癌症
HK1237825A1 (en) Applications of plasma mitochondrial dna analysis

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 14 FEB 2020

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT FILED 14 FEB 2020

FGA Letters patent sealed or granted (standard patent)